The analysis of survival data: The Kaplan-Meier method

Kidney International

Volumn 74, Issue 5, 2008, Pages 560-565

  Jager, Kitty J ^a,d   Van Dijk, Paul C ^a   Zoccali, Carmine ^b   Dekker, Friedo W ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OSPEDALI RIUNITI   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Kaplan Meier method; Statistics; Survival analysis

Indexed keywords

ARTICLE; HEART INFARCTION; HYPOTHESIS; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY FUNCTION; LOG RANK TEST; PRIORITY JOURNAL; SURVIVAL;

BIOMETRY; DIABETIC NEPHROPATHIES; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PROGNOSIS; RENAL REPLACEMENT THERAPY;

EID: 49749105205     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.217     Document Type: Article

References (13)

1. ERA-EDTA Registry: ERA-EDTA Registry 2005 Annual Report Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, June 2007.
2. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259.
3. Stel VS, van Dijk PC, van Manen JG et al. Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant 2005; 20: 2803-2811.
4. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248.
5. Drüeke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084.
6. Altman DG, Bland JM. Time to event (survival) data. BMJ 1998; 317: 468-469.
7. Jager KJ, Zoccali C, Kramar R et al. Measuring disease occurrence. Kidney Int 2007; 72: 412-415.
8. Bland JM, Altman DG. Survival probabilities (the Kaplan-Meier method). BMJ 1998; 317: 1572.
9. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med 1999; 341: 1725-1730.
10. Van Dijk PC, Jager KJ, Stengel B et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005; 67: 1489-1499.
11. Bland JM, Altman DG. The logrank test. BMJ 2004; 328: 1073.
12. van Manen JG, van Dijk PC, Stel VS et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007; 22: 187-195.
13. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002; 359: 1686-1689.